Social equity was meant to be the cannabis industry’s correction to decades of harm. Years in, the results are uneven. Some cannabis equity programs have opened real doors, while others have stalled under licensing backlogs, capital gaps, and rules that look...
The 280E landscape is shifting faster than most operators can track, and the decisions you make now could mean recovering serious cash or leaving it on the table. This session translates recent 280E developments into clear, actionable tax strategy for cannabis...
The hemp industry is approaching a challenging regulatory path. Pending federal and state enforcement deadlines aim to close the loophole that let intoxicating, hemp-derived products flourish, redefining legal hemp by total-THC content rather than delta-9 alone. For...
Rescheduling has sparked more questions than answers, and operators are making decisions in a fog of speculation. This session cuts through the noise with a clear-eyed look at what a move to Schedule III genuinely changes for cannabis businesses, and what stays the...
